Ferrum Iodatum

The dosage of Ferrous must be individualized based on the severity of the iron deficiency and the patient's tolerance. For the treatment of iron deficiency anemia, the typical adult dose ranges from 60 mg to 200 mg of elemental iron per day, usually divided into two or three doses. It is important to note that the dosage is often expressed in terms of the salt (e.g., Ferrous Phosphate) rather than the elemental iron content; patients should always verify the 'elemental iron' amount on the supplement label. For the prevention of deficiency (prophylaxis), lower doses of 15 mg to 30 mg daily may be sufficient.

Pediatric dosing is strictly weight-based to prevent toxicity. For iron deficiency anemia in children, the standard dose is 3 mg to 6 mg of elemental iron per kilogram of body weight per day, divided into three doses. For prophylaxis in infants, the dose is typically 1 mg to 2 mg/kg/day. Healthcare providers emphasize that iron supplements must be kept out of reach of children, as accidental overdose is a leading cause of fatal poisoning in the pediatric population.

Renal Impairment

No specific dose adjustments are generally required for patients with renal impairment. However, these patients may have complex anemia (often involving erythropoietin deficiency) and may require intravenous iron if oral absorption is inadequate.

Hepatic Impairment

Caution is advised in patients with chronic liver disease. Since the liver is the primary storage site for iron, patients with hepatic impairment are at a higher risk of iron overload and subsequent tissue damage. Regular monitoring of serum ferritin and transferrin saturation is mandatory.

Elderly Patients

Elderly patients may require lower starting doses due to a higher prevalence of gastrointestinal sensitivity and constipation. Furthermore, underlying causes of anemia in the elderly (such as occult GI malignancy) must be ruled out before starting Ferrous.

To maximize the effectiveness of Ferrous, patients should follow these specific guidelines:

• Timing: For optimal absorption, take Ferrous on an empty stomach, either 1 hour before or 2 hours after meals.
• With Food: If severe stomach upset occurs, Ferrous may be taken with a small amount of food, though this will reduce absorption. Avoid taking iron with dairy products (milk, cheese), eggs, spinach, or whole-grain breads, as these contain substances that bind iron and prevent its uptake.
• Vitamin C: Taking Ferrous with a glass of orange juice or a 250 mg Vitamin C supplement can significantly enhance absorption.
• Administration: Swallow tablets or capsules whole. Do not crush or chew extended-release formulations, as this can cause a sudden release of iron and increase the risk of gastric irritation.
• Liquid Forms: If using liquid iron, mix the dose with water or fruit juice and drink it through a straw to prevent temporary staining of the teeth. Brushing the teeth after the dose can also help.

If you miss a dose of Ferrous, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of gastrointestinal side effects and toxicity.

Iron overdose is a medical emergency. Early signs include severe vomiting, diarrhea (often bloody), stomach pain, and a metallic taste. Late-stage symptoms can include low blood pressure (hypotension), rapid heart rate, liver failure, and coma. If an overdose is suspected, especially in a child, contact a poison control center or emergency services immediately. Treatment typically involves gastric lavage and the administration of a chelating agent like deferoxamine.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance, as excessive iron can lead to permanent organ damage.

Gastrointestinal side effects are the most frequent complications associated with Ferrous therapy. These effects are often dose-dependent and include:

• Constipation: This is the most common complaint. Iron can slow down intestinal motility and alter the water balance in the colon, leading to hard, infrequent stools.
• Dark or Black Stools: Patients should be reassured that this is a harmless side effect. It occurs because unabsorbed iron reacts with hydrogen sulfide in the gut to form iron sulfide, which is black. However, it is important to distinguish this from 'melena' (tarry, foul-smelling stools caused by internal bleeding).
• Abdominal Cramping and Nausea: These symptoms typically occur shortly after taking the medication and may be accompanied by a feeling of fullness or bloating.

• Diarrhea: While constipation is more common, some patients experience loose stools as the gut reacts to the irritating effects of the iron salt.
• Heartburn or Acid Reflux: Iron can irritate the esophageal lining, especially if the patient lies down immediately after taking the dose.
• Vomiting: This is more likely to occur if iron is taken on a completely empty stomach at high doses.

• Teeth Staining: Primarily associated with liquid formulations; this is usually superficial and can be removed by professional dental cleaning.
• Allergic Reactions: Though rare, some individuals may develop a rash, itching, or hives.
• Gastric Erosions: In rare cases of high-dose therapy, the direct contact of iron tablets with the stomach lining can cause small sores or erosions.

> Warning: Stop taking Ferrous and call your doctor immediately if you experience any of these symptoms, as they may indicate a severe reaction or toxicity:

• Severe Upper Abdominal Pain: This could indicate significant gastric irritation or a potential ulceration.
• Hematemesis (Vomiting Blood): This is a sign of severe gastrointestinal bleeding and requires emergency evaluation.
• Anaphylaxis: Signs include swelling of the face, lips, or tongue, severe dizziness, and difficulty breathing. This is a life-threatening emergency.
• Fever and Chills: While rare with oral iron, these symptoms could indicate an underlying systemic reaction or an unrelated infection that needs diagnosis.
• Blood in the Stool: Bright red blood in the stool (hematochezia) is not a normal side effect of iron and must be investigated by a physician.

The most significant risk of long-term, unmonitored Ferrous use is Iron Overload (Hemosiderosis). Because the body cannot easily excrete iron, chronic excessive intake leads to iron deposits in the liver, heart, and pancreas. Over time, this can lead to cirrhosis, heart failure (cardiomyopathy), and diabetes (bronze diabetes). Regular blood tests, including transferrin saturation and ferritin levels, are essential for anyone on long-term iron therapy to ensure levels remain within the therapeutic window.

FDA Black Box Warning: Accidental Overdose in Children

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. Even a small number of high-potency iron tablets can be lethal to a young child. Many Ferrous products are packaged in child-resistant containers or individual blisters to mitigate this risk, but vigilance is still required.

Report any unusual symptoms to your healthcare provider. If side effects are intolerable, your doctor may suggest a different iron salt or a lower, more frequent dosing schedule.

Ferrous should only be used when a deficiency has been clinically confirmed by a healthcare professional. Taking iron when it is not needed can lead to toxicity and interfere with the diagnosis of other medical conditions. Patients should be aware that iron supplements can interfere with certain diagnostic tests, such as fecal occult blood tests (used to screen for colon cancer), potentially causing false-positive results.

Accidental Overdose in Children: As noted in the side effects section, the FDA requires a prominent warning on all iron-containing supplements regarding the risk of fatal poisoning in children. This is the most critical safety warning for Ferrous. Healthcare providers advise that iron should be stored in a locked cabinet or on a high shelf that is inaccessible to toddlers and young children.

• Gastrointestinal Disease: Use Ferrous with extreme caution if you have a history of peptic ulcer disease, inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis, or regional enteritis. Iron can be highly irritating to the mucosal lining and may exacerbate these conditions.
• Hemoglobinopathies: Patients with conditions like thalassemia or sickle cell anemia may have high iron levels despite being anemic. Supplementing with Ferrous in these cases can lead to dangerous iron overload.
• Repeat Blood Transfusions: If you receive frequent blood transfusions, you are already receiving significant amounts of iron. Oral Ferrous is generally contraindicated in these patients to avoid systemic iron toxicity.
• Hypersensitivity: While oral iron rarely causes anaphylaxis compared to intravenous iron, patients with known sensitivities to any component of the Ferrous Phosphate formulation should avoid use.

Effective Ferrous therapy requires ongoing laboratory monitoring to ensure efficacy and safety. Your healthcare provider will typically order the following tests:

• Complete Blood Count (CBC): To monitor hemoglobin and hematocrit levels. An increase in reticulocytes (young red blood cells) is usually seen within 7-10 days of starting therapy.
• Serum Ferritin: This reflects the body's total iron stores. The goal of therapy is often to bring ferritin levels into the normal range (typically >30-50 ng/mL).
• Transferrin Saturation (TSAT): To ensure iron is being effectively transported to the bone marrow.
• Liver Function Tests (LFTs): Recommended for patients on long-term, high-dose therapy to screen for early signs of iron-induced hepatic injury.

Ferrous does not typically cause drowsiness or impairment of cognitive function. It is generally considered safe to drive or operate machinery while taking this supplement. However, if you experience severe dizziness due to the underlying anemia itself, you should wait until your symptoms improve before engaging in these activities.

Chronic alcohol consumption can increase the absorption of iron and may also contribute to liver damage. Combining heavy alcohol use with iron supplementation increases the risk of iron overload and hepatotoxicity. It is advisable to limit alcohol intake while taking Ferrous.

Do not stop taking Ferrous prematurely. Even after your hemoglobin levels return to normal, your doctor may recommend continuing the supplement for several months to fully replenish your body's iron stores (ferritin). There is no withdrawal syndrome associated with stopping Ferrous, but stopping too early may lead to a relapse of anemia.

> Important: Discuss all your medical conditions with your healthcare provider before starting Ferrous, especially if you have a history of liver disease or stomach ulcers.

While few drugs are strictly contraindicated, Ferrous should not be used simultaneously with Dimercaprol (a chelating agent used for heavy metal poisoning). Iron forms a toxic complex with dimercaprol that can cause severe kidney damage. If both are needed, they must be administered at different times or alternative therapies must be used.

• Antibiotics (Tetracyclines and Fluoroquinolones): Ferrous can bind to these antibiotics (a process called chelation) in the gut, preventing both the iron and the antibiotic from being absorbed. This can lead to treatment failure for the infection. Examples include doxycycline, ciprofloxacin, and levofloxacin. These should be taken at least 2 hours before or 4 to 6 hours after Ferrous.
• Bisphosphonates: Used for osteoporosis (e.g., alendronate, risedronate). Iron significantly reduces the absorption of these drugs. They should be separated by at least 2 hours.
• Levothyroxine: Iron can bind to thyroid hormone replacement medication, leading to hypothyroidism symptoms. Patients should separate these doses by at least 4 hours.

• Antacids and Proton Pump Inhibitors (PPIs): Drugs like omeprazole, ranitidine, or calcium carbonate reduce stomach acid. Because iron requires an acidic environment for optimal absorption, these medications can make Ferrous less effective. If an antacid is necessary, take it at least 2 hours away from your iron dose.
• Levodopa and Methyldopa: Iron can reduce the absorption of these Parkinson's and blood pressure medications, potentially reducing their clinical effect.
• Mycophenolate Mofetil: An immunosuppressant used in transplant patients; its absorption is significantly decreased when taken with iron.

• Dairy Products: Calcium and proteins in milk and cheese inhibit iron absorption. Avoid dairy for 2 hours before and after your dose.
• Coffee and Tea: These contain tannins and polyphenols that bind iron. Drinking tea with a meal can reduce iron absorption by up to 60-70%.
• High-Fiber Foods: Phytates found in whole grains and legumes can also interfere with iron uptake.
• Eggs: Contain phosvitin, a protein that binds iron and sequester it from absorption.

• Calcium Supplements: Calcium competes with iron for the same transport receptors in the intestine. They should be taken at different times of the day.
• Zinc and Copper: High doses of iron can interfere with the absorption of these essential trace minerals, and vice versa. Long-term iron users should ensure their diet or multivitamin provides adequate zinc and copper.
• St. John's Wort: While not a direct chemical interaction, St. John's Wort can affect overall gut motility and may theoretically alter iron transit time.

• Fecal Occult Blood Test (Guaiac-based): Oral iron can cause false-positive results in some types of stool tests used for colon cancer screening. Patients should inform their doctor they are taking iron before providing a stool sample.
• Bone Scans: Iron can occasionally interfere with the uptake of technetium-99m used in bone imaging, though this is rare with oral dosing.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A simple adjustment in timing can often prevent most of these interactions.

Ferrous must NEVER be used in the following circumstances:

• Iron Overload Syndromes (Hemochromatosis): This is a genetic condition where the body absorbs too much iron. Adding Ferrous supplements can lead to rapid organ failure and death.
• Hemosiderosis: A condition characterized by excessive iron deposits in the tissues, often due to repeated blood transfusions or chronic hemolysis.
• Hemolytic Anemia: Unless a concurrent iron deficiency is proven, iron is contraindicated in hemolytic anemia (where red blood cells are destroyed). In these cases, iron is already being released from the broken-down cells and recycled; adding more can lead to toxicity.
• Hypersensitivity: A known severe allergy to Ferrous Phosphate or any inactive ingredients in the formulation (e.g., dyes, fillers).

In these cases, a healthcare provider must carefully weigh the risks and benefits:

• Peptic Ulcer Disease: The irritating nature of iron can prevent the healing of ulcers or cause them to bleed.
• Ulcerative Colitis and Crohn's Disease: Oral iron can worsen the inflammation and oxidative stress in the colon during a flare-up. In some cases, intravenous iron is preferred for these patients.
• Frequent Blood Transfusions: As each unit of blood contains approximately 250 mg of iron, oral supplementation is usually unnecessary and potentially harmful.
• Porphyria Cutanea Tarda: A metabolic disorder where iron can exacerbate skin blistering and liver damage.

While cross-sensitivity between different oral iron salts (like moving from Ferrous Phosphate to Ferrous Sulfate) is rare, patients who have had severe gastric intolerance to one salt may experience it with others. However, this is usually a physiological irritation rather than an allergic cross-reactivity. There is no known cross-sensitivity between oral iron and other non-mineral medications.

> Important: Your healthcare provider will evaluate your complete medical history, including any genetic conditions like hemochromatosis, before prescribing Ferrous.

FDA Pregnancy Category: Not formally assigned (standard mineral).

During pregnancy, iron requirements increase significantly to support the expanded maternal blood volume and the growth of the fetus and placenta. According to the American College of Obstetricians and Gynecologists (ACOG), pregnant women need approximately 27 mg of elemental iron per day. Ferrous is considered safe and is routinely prescribed during pregnancy. It is most critical during the second and third trimesters. While iron is not teratogenic (does not cause birth defects), excessive doses should be avoided to prevent maternal toxicity.

Iron is naturally present in breast milk, and the amount does not significantly change based on maternal iron intake. Taking Ferrous supplements at recommended doses is considered safe for breastfeeding mothers. It does not adversely affect the nursing infant. However, breastfeeding mothers should still be monitored for anemia, as the physical toll of childbirth can deplete iron stores.

Ferrous is approved for use in children for both the treatment and prevention of iron deficiency. It is particularly important for infants who were born prematurely or those who are exclusively breastfed beyond six months without the introduction of iron-rich solid foods. However, as previously emphasized, the risk of accidental poisoning is extremely high. Pediatric use must always be supervised by a pediatrician with strict adherence to weight-based dosing.

Elderly patients (65 and older) are at a higher risk of iron deficiency due to poor diet, reduced gastric acid secretion (achlorhydria), and the use of medications like NSAIDs that can cause minor GI bleeding. While Ferrous is effective in this population, older adults are more prone to severe constipation and fecal impaction. Healthcare providers often recommend a stool softener be taken alongside Ferrous in geriatric patients.

Patients with chronic kidney disease (CKD) often develop anemia due to decreased erythropoietin production. While oral Ferrous can be used, many patients with advanced CKD (Stage 4 or 5) have high levels of hepcidin, which blocks oral iron absorption. These patients may require intravenous iron to achieve target hemoglobin levels. No specific dose adjustment is needed for oral Ferrous, but efficacy may be limited.

In patients with liver cirrhosis or chronic hepatitis, the liver's ability to store and regulate iron is compromised. These patients should be treated with extreme caution, as they are at an increased risk of developing secondary iron overload, which can accelerate liver scarring (fibrosis). Regular monitoring of iron studies is essential.

> Important: Special populations, particularly pregnant women and the elderly, require individualized medical assessment to determine the safest and most effective dose of Ferrous.

Ferrous Phosphate acts as an exogenous source of elemental iron. Once it reaches the acidic environment of the stomach, the salt dissociates, releasing ferrous ions (Fe2+). These ions are transported across the apical membrane of the enterocytes in the duodenum by the Divalent Metal Transporter 1 (DMT1). Inside the cell, the iron is either stored as ferritin or exported into the blood via the protein ferroportin. In the blood, the iron is oxidized to its ferric state (Fe3+) by hephaestin and binds to transferrin. This iron is then delivered to the bone marrow, where it is used by erythroblasts to synthesize heme, the oxygen-binding component of hemoglobin. This process is tightly regulated by hepcidin, a liver-derived hormone that degrades ferroportin when iron levels are high, thus preventing further absorption.

The pharmacodynamic effect of Ferrous is the increase in hemoglobin production and the replenishment of depleted iron stores. The response is not immediate; while reticulocyte counts may rise within 7 to 10 days, a significant increase in hemoglobin typically takes 2 to 4 weeks. Full replenishment of iron stores (measured by ferritin) can take 3 to 6 months of continuous therapy. There is no evidence of tolerance development to iron; however, absorption efficiency decreases as the body's iron stores become saturated.

| Parameter | Value |

|---|---|

| Bioavailability | 10% to 35% (higher in deficiency) |

| Protein Binding | >99% (bound to transferrin) |

| Half-life | N/A (physiologic recycling) |

| Tmax | 2 to 4 hours |

| Metabolism | Not metabolized; recycled via macrophages |

| Excretion | Minimal (1 mg/day via skin/GI sloughing) |

Ferrous Phosphate has the molecular formula Fe3(PO4)2 and a molecular weight of approximately 357.48 g/mol. It is an inorganic salt that appears as a grayish-white to blue-green powder. It is poorly soluble in water but dissolves in mineral acids, which is why gastric acidity is crucial for its absorption. In pharmaceutical applications, it is often preferred in certain food-grade supplements due to its relative stability compared to other iron salts.

Ferrous belongs to the therapeutic class of Hematinics and the pharmacological class of Iron Salts. Related medications in this class include Ferrous Sulfate, Ferrous Gluconate, and Ferrous Fumarate. While they all provide elemental iron, they differ in their percentage of elemental iron by weight (e.g., Ferrous Sulfate is 20% elemental iron, while Ferrous Fumarate is 33%).